patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: question to Craig Bird and his answer below on recent pps decline

 

A well done post and I believe many have the same sentiment.

As a lurker who was given this company to look at and do my own DD, I will state that posts about all sides of the company are appreciated.  That's just my take.  I like to see both sides and weigh those comments with my other DD before I buy any stock, especially speculative penny stocks.

Please don't misunderstand, I do not like bashers and those that harp on the past.  I do like varied opines.

Have a Great New Years!

John 

 

Share
New Message
Please login to post a reply